Drug Type Hormone |
Synonyms Choriomon |
Target |
Action agonists |
Mechanism FSHR agonists(Follicle-stimulating hormone receptor agonists), LHCGR agonists(Luteinizing hormone/Choriogonadotropin receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Infertility | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Abortion, Spontaneous | Phase 3 | Iran | 30 Nov 2015 | |
Ovarian Hyperstimulation Syndrome | Phase 3 | Egypt | 30 Jun 2015 | |
Endometriosis | Phase 3 | Egypt | 01 Jun 2015 | |
Infertility, Male | Phase 3 | Egypt | 01 Jun 2015 | |
Female infertility of tubal origin | Phase 3 | Switzerland | 01 Aug 2005 | |
Ovarian Stimulations | Phase 1 | Canada | 15 Sep 2024 |
Phase 1 | Acute Graft Versus Host Disease amphiregulin (AREG) | plasma epidermal growth factor (EGF) | 26 | hCG/EGF | incvjliwsd(dzvqkzknma) = zrpuxyrmdk kikolmtmfq (zhsyqdryru ) View more | Positive | 01 Mar 2019 | |
Phase 3 | - | 147 | Highly purified human Choriogonadotrophin (HP-hCG) | sqzsgfkded(phdduunpes) = aoyxefhxjc xmpkklgjfp (drmfgijpyw ) | Positive | 01 Feb 2013 | |
Recombinant hCG (r-hCG) | sqzsgfkded(phdduunpes) = vgkqskgwyj xmpkklgjfp (drmfgijpyw ) |